Medical Data Vision Co., Ltd.
Notice Regarding Approval Resolution on Share Consolidation, Abolition of the Unit Share System, and Partial Amendment to the Articles of Incorporation
The total number of outstanding shares will decrease by 37,856,768 shares due to the share consolidation, effective date April 28, 2026. Delisting scheduled for April 24, 2026.
Key Figures
- Consolidation Ratio: 7,253,607 shares consolidated into 2 shares
- Decrease in Total Number of Outstanding Shares: 37,856,768 shares
- Total Number of Outstanding Shares After Effectiveness: 10 shares
AI要約
Overview of Capital Policy
Medical Data Vision Co., Ltd. approved at an extraordinary general meeting of shareholders held on March 24, 2026, the consolidation of common stock (consolidating 7,253,607 shares into 2 shares), abolition of the unit share system, and partial amendment to the articles of incorporation. As a result, the total number of outstanding shares will decrease by 37,856,768 shares, with the effective date set for April 28, 2026. Additionally, following the share consolidation, the company's shares are scheduled to be delisted from the Tokyo Stock Exchange Prime Market on April 24, 2026.
Impact on Shareholders and Future Schedule
In connection with the share consolidation, fractional shares less than one share will be sold, and the proceeds will be distributed to shareholders. The sale price per share is expected to be 1,693 yen, and Nippon Life Insurance Company is anticipated to purchase these shares. The procedures to sell fractional shares will involve filing for court approval in mid-May 2026, purchasing in mid-June, and delivering proceeds to shareholders by mid-August. Consequently, ultimately only the tender offeror and SBI Holdings will remain as shareholders.
